US5360897A
(en)
*
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
ATE87215T1
(de)
*
|
1987-07-21 |
1993-04-15 |
Stolle Res & Dev |
Verfahren zum erhalten von immunregulierenden faktoren mittels saeugetierimmunisierung.
|
US5785973A
(en)
*
|
1988-02-01 |
1998-07-28 |
Praxis Biologics, Inc. |
Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
|
WO1989006974A2
(fr)
*
|
1988-02-01 |
1989-08-10 |
Praxis Biologics, Inc. |
Epitopes de cellules t a titre de molecules porteuses pour vaccins conjugues
|
DE3919915A1
(de)
*
|
1989-06-19 |
1990-12-20 |
Boehringer Mannheim Gmbh |
Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
|
CA2064194A1
(fr)
*
|
1989-07-27 |
1991-01-28 |
Nelson Teng |
Produits de conjugaison entre un lipide a et un vecteur immunogene et leur utilisation comme vaccin
|
US5648241A
(en)
|
1989-09-15 |
1997-07-15 |
The General Hospital Corporation |
Conjugate vaccine against group B streptococcus
|
CA2047073A1
(fr)
*
|
1990-07-19 |
1992-01-20 |
William J. Leanza |
Vaccins coconjugues comportant une proteine immunogene, des peptides lies a vih et des fractions anioniques
|
IE912535A1
(en)
*
|
1990-07-27 |
1992-01-29 |
Res Dev Foundation |
Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
|
US5843463A
(en)
*
|
1990-12-21 |
1998-12-01 |
Antexbiologics, Inc. |
Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
|
FR2682388B1
(fr)
*
|
1991-10-10 |
1995-06-09 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
|
DE4224884A1
(de)
*
|
1992-07-28 |
1994-02-03 |
Batenus Gmbh & Co Kg |
Verfahren zur Rückgewinnung von Rohstoffen aus vorsortiert gesammeltem, verbrauchten Gut, insbesondere aus verbrauchten elektrochemischen Batterien und Akkumulatoren
|
US5445817A
(en)
*
|
1992-08-21 |
1995-08-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
|
ZA937034B
(en)
*
|
1992-09-24 |
1995-06-23 |
Brigham & Womens Hospital |
Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
|
JP4163251B2
(ja)
*
|
1992-09-24 |
2008-10-08 |
ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド |
グループbストレプトコッカス・タイプ▲ii▼およびタイプ▲v▼多糖−蛋白質接合ワクチン
|
US5274122A
(en)
*
|
1992-10-15 |
1993-12-28 |
Merck & Co., Inc. |
Acidic derivatives of homocysteine thiolactone
|
ES2126616T3
(es)
*
|
1992-10-27 |
1999-04-01 |
American Cyanamid Co |
Vacuna pediatrica combinada, con una inmunogenecidad aumentada de cada componente de la vacuna.
|
US5554730A
(en)
*
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
US6153406A
(en)
*
|
1993-07-23 |
2000-11-28 |
North American Vaccine, Inc. |
Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
|
US5565204A
(en)
*
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
GB9422096D0
(en)
*
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
US6284884B1
(en)
|
1995-06-07 |
2001-09-04 |
North American Vaccine, Inc. |
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
|
US5811102A
(en)
|
1995-06-07 |
1998-09-22 |
National Research Council Of Canada |
Modified meningococcal polysaccharide conjugate vaccines
|
EP0831901B2
(fr)
*
|
1995-06-07 |
2005-12-07 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccins comprenant un conjugue antigene de polysaccharide-proteine porteuse et une proteine porteuse libre
|
US6207157B1
(en)
|
1996-04-23 |
2001-03-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for nontypeable Haemophilus influenzae
|
DK0939647T4
(da)
†
|
1996-08-27 |
2006-10-23 |
Novartis Vaccines & Diagnostic |
Neisseria Meningitidis-serogruppe B-glycokonjugat og fremgangsmåde til anvendelse deraf
|
US6267961B1
(en)
|
1996-11-22 |
2001-07-31 |
Baxter International Inc. |
Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
|
US6426074B1
(en)
*
|
1997-03-19 |
2002-07-30 |
The Brigham And Women's Hospital Inc. |
Group B Streptococcus vaccine
|
US6676943B1
(en)
*
|
1997-04-24 |
2004-01-13 |
Regents Of The University Of Minnesota |
Human complement C3-degrading protein from Streptococcus pneumoniae
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
US6306404B1
(en)
|
1998-07-14 |
2001-10-23 |
American Cyanamid Company |
Adjuvant and vaccine compositions containing monophosphoryl lipid A
|
US8609614B2
(en)
|
1998-07-22 |
2013-12-17 |
Vanderbilt University |
GBS toxin receptor compositions and methods of use
|
KR100704826B1
(ko)
*
|
1998-08-19 |
2007-04-09 |
박스터 헬쓰케어 에스.에이. |
N-아크릴로일화된 폴리사카라이드를 사용하여 제조된백신으로서 사용하기에 적합한 면역원성β-프로피온아미도-결합 폴리사카라이드 단백질 컨쥬게이트
|
FR2791895B1
(fr)
*
|
1999-03-23 |
2001-06-15 |
Pasteur Merieux Serums Vacc |
Utilisation de trehalose pour stabiliser un vaccin liquide
|
US6635261B2
(en)
|
1999-07-13 |
2003-10-21 |
Wyeth Holdings Corporation |
Adjuvant and vaccine compositions containing monophosphoryl lipid A
|
US6846486B1
(en)
*
|
2000-02-24 |
2005-01-25 |
Advanced Biotherapy Concepts, Inc. |
Method of treating allergy by administering an anti-histamine antibody
|
EP2957300B1
(fr)
|
2001-01-23 |
2021-07-14 |
Sanofi Pasteur Inc. |
Vaccin conjugué de protéine et de polysaccharide pour méningococcie polyvalente
|
JP2004533236A
(ja)
*
|
2001-04-13 |
2004-11-04 |
ワイエス |
化膿性連鎖球菌(Streptococcuspyogenes)の表面タンパク質
|
US20070128229A1
(en)
*
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
WO2003015815A1
(fr)
|
2001-08-21 |
2003-02-27 |
The Brigham And Women's Hospital, Inc. |
Vaccins conjugues ameliores
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
US8129330B2
(en)
|
2002-09-30 |
2012-03-06 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
US20040062748A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
EP2289546A3
(fr)
|
2003-01-30 |
2011-03-30 |
Novartis Vaccines and Diagnostics S.r.l. |
Vaccins injectables contre les multiples serogroupes du meningocoque
|
WO2005044861A1
(fr)
*
|
2003-10-31 |
2005-05-19 |
Wyeth Holdings Corporation |
Polysaccharides de helicobacter pylori
|
SG149013A1
(en)
|
2003-12-17 |
2009-01-29 |
Wyeth Corp |
Immunogenic peptide carrier conjugates and methods of producing same
|
MY144231A
(en)
|
2003-12-17 |
2011-08-15 |
Wyeth Corp |
Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
|
US7858101B2
(en)
|
2004-11-01 |
2010-12-28 |
The Brigham And Women's Hospital, Inc. |
Modified streptococcal polysaccharides and uses thereof
|
JP2008523815A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのヒト化アミロイドβ抗体
|
US7709001B2
(en)
*
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US20070184072A1
(en)
*
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
TWI445545B
(zh)
|
2005-04-08 |
2014-07-21 |
Wyeth Corp |
多價肺炎球菌多醣-蛋白質共軛物組合物
|
US7955605B2
(en)
*
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
AU2011253684B8
(en)
*
|
2005-04-08 |
2013-07-11 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US10828361B2
(en)
|
2006-03-22 |
2020-11-10 |
Glaxosmithkline Biologicals Sa |
Regimens for immunisation with meningococcal conjugates
|
SI2004225T1
(sl)
|
2006-03-22 |
2012-08-31 |
Novartis Ag |
Reĺ˝imi za imunizacijo z meningokoknimi konjugati
|
AR060187A1
(es)
*
|
2006-03-30 |
2008-05-28 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
US8563523B2
(en)
|
2007-09-07 |
2013-10-22 |
University Of Georgia Research Foundation, Inc. |
Synthetic lipid A derivative
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
EP2356135B1
(fr)
|
2008-11-05 |
2017-10-25 |
Wyeth LLC |
Composition immunogène à multiples composants pour la prévention d'une maladie streptococcique bêta-hémolytique (bhs)
|
EP2387417B1
(fr)
|
2009-01-16 |
2016-05-11 |
University of Maryland, Baltimore |
Vaccin à large spectre contre les salmonelles non typhoïdiques
|
BRPI1014494A2
(pt)
|
2009-04-30 |
2016-08-02 |
Coley Pharm Group Inc |
vacina pneumocócica e usos da mesma
|
US8568735B2
(en)
|
2009-06-22 |
2013-10-29 |
Wyeth Llc |
Immunogenic compositions of Staphylococcus aureus antigens
|
KR20140119165A
(ko)
|
2009-06-22 |
2014-10-08 |
와이어쓰 엘엘씨 |
황색포도상구균 혈청형 5 및 8 협막 다당류 접합체 면역원성 조성물 및 이의 제조 방법
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
PL2394663T3
(pl)
*
|
2010-05-31 |
2022-02-21 |
Laboratorios Farmaceuticos Rovi, S.A. |
Kompozycje do wstrzykiwania implantów biodegradowalnych in-situ
|
EP3626263A1
(fr)
|
2010-06-04 |
2020-03-25 |
Wyeth LLC |
Formulations vaccinales
|
US20130259896A1
(en)
|
2010-12-22 |
2013-10-03 |
Lakshmi Khandke |
Stable Immunogenic Compositions of Staphylococcus Aureus Antigens
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
KR102057217B1
(ko)
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075201A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
WO2014097099A2
(fr)
|
2012-12-20 |
2014-06-26 |
Pfizer Inc. |
Procédé de glycoconjugaison
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
US11241489B2
(en)
|
2016-08-05 |
2022-02-08 |
Sanofi Pasteur Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CA3031797A1
(fr)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Composition d'un conjugue polysaccharide-proteine pneumococcique multivalent
|
IL265623B2
(en)
|
2016-09-30 |
2023-04-01 |
Biological E Ltd |
Multivalent vaccines for lung spot that include polysaccharide-protein conjugates
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
WO2018144438A1
(fr)
|
2017-01-31 |
2018-08-09 |
Merck Sharp & Dohme Corp. |
Procédés de production de conjugués protéine-polysaccharide capsulaire à partir du sérotype 19f de streptococcus pneumoniae
|
CA3052621A1
(fr)
|
2017-02-03 |
2018-08-09 |
Schadeck, Eva Barbara |
Compositions de conjugue saccharide d'haemophilus influenzae-excipient et leurs utilisations
|
CA3066911C
(fr)
|
2017-06-10 |
2022-05-24 |
Inventprise, Llc |
Vaccins conjugues multivalents avec des polysaccharides conjugues bivalents ou multivalents qui conferent une immunogenicite et une avidite ameliorees
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
KR20200051004A
(ko)
|
2017-09-07 |
2020-05-12 |
머크 샤프 앤드 돔 코포레이션 |
폐렴구균 폴리사카라이드 및 면역원성 폴리사카라이드-담체 단백질 접합체에서의 그의 용도
|
PE20201338A1
(es)
|
2017-12-06 |
2020-11-25 |
Merck Sharp & Dohme |
Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y metodos de uso de estos
|
CN113453708A
(zh)
|
2018-12-19 |
2021-09-28 |
默沙东公司 |
包含肺炎链球菌多糖-蛋白缀合物的组合物及其使用方法
|
JP2022542316A
(ja)
|
2019-07-31 |
2022-09-30 |
サノフィ パスツール インコーポレイテッド |
多価肺炎球菌多糖体-タンパク質コンジュゲート組成物およびその使用方法
|
KR20220102871A
(ko)
|
2021-01-14 |
2022-07-21 |
(주)셀트리온 |
다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
|
TW202245835A
(zh)
|
2021-02-04 |
2022-12-01 |
美商默沙東有限責任公司 |
用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
|